CURRENTLY ON AIR ⇒
  • Afternoon Mix with Irfaan Aboo
    Saturday, 4:05 pm - 5:00 pm
    [ - ]

feedback@radioislam.org.za

logo


((( Listen Live )))))
Radio Islam Logo


SAHPRA clears Benylin Paediatric cough syrup after recall over toxic chemical fears

Azra Hoosen | ah@radioislam.co.za
7 June 2024 | 10:30 CAT
2 min read

South African health authorities have cleared Benylin Paediatric syrup of any toxin contamination after conducting independent tests on two affected batches. This comes after recalls were issued in five African countries due to reports of high levels of diethylene glycol in the syrup, which can be harmful.

Although the affected batches were produced in South Africa, tests revealed no traces of the toxin, reassuring the public about the product’s safety.

The CEO of the SA Health Products Regulatory Authority (SAHPRA) emphasised ongoing monitoring to ensure public health protection.

In an interview with Radio Islam, Deon Poovan, Senior Manager of SAHPRA’s Inspectorate and Regulatory Compliance, clarified that due to the severity of diethylene glycol contamination in medicines, SAHPRA initiated a precautionary recall.

“From initial investigations, we found that the batch that Nigeria found was linked to another batch, which is why you see two batch numbers of Benylin Paediatric being recalled by SAHPRA. Since then, SAHPRA has conducted its own independent testing of samples of these two batches and found they do not contain traces of diethylene glycol and, therefore safe for consumption,” he said.

According to Poovan, the recall only pertained to two specific batches, emphasising that Benylin Paediatric consistently adheres to good manufacturing practices. Additionally, he noted that the manufacturer has cooperated fully with SAHPRA, conducting their own rigorous testing and root-cause investigations.

It has been reported that no adverse events have so far been reported in South Africa or other African countries relating to the syrup, though Kenya, Rwanda, Tanzania and Zimbabwe also issued recalls.

“There is no information about what happened in Nigeria and Kenya. As a regulator, we are letting our public know what we found as part of our independent investigation,” said Poovan.

Additionally, Kenvue, the company that now owns the Benylin brand following its spinoff from J&J last year, stated that their independent tests of the recalled batches revealed no presence of either diethylene glycol or another closely linked toxin, ethylene glycol.

LISTEN to the full interview with Ml Sulaimaan Ravat and SAHPRA’s Deon Poovan, here.

ADVERTISE HERE

Prime Spot!!!

Contact:
advertisingadmin@radioislam.co.za 

Related Articles

2026 HPV Vaccination Campaign Kicks Off Nationwide

2026 HPV Vaccination Campaign Kicks Off Nationwide

Neelam Rahim | neelam@radioislam.co.za 3-minute read 03 February 2026 South Africa’s 2026 HPV vaccination drive officially kicked off today, targeting girls aged nine and older in an effort to curb cervical cancer one of the country’s deadliest yet most preventable...

read more
Drowning In Debt

Drowning In Debt

Rabia Mayet | rabiamayet@radioislam.co.za 05 February 2026 2-minute read A decade of rising living costs, payday loans, and online gambling have seen South Africans using 71% of their salary towards debt payment. Executive head of Debt Busters, Benay Sager, says that...

read more
Real Power Dynamics

Real Power Dynamics

Rabia Mayet | rabiamayet@radioislam.co.za 03 February 2026 2-minute read As registration deadlines loom for homeowners to register rooftop solar and battery systems, anxiety around the electricity issue mounts. Prof Vally Padayachee confirms that the media statement...

read more
Simply A Matter Of Following The Process

Simply A Matter Of Following The Process

Rabia Mayet | rabiamayet@radioislam.co.za 29 January 2026 2-minute read Following the horrific accident of 14 children who lost their lives when travelling in a scholar transport taxi, several provinces have swooped in to assess scholar transport vehicles, hundreds of...

read more

Subscribe to our Newsletter

0 Comments